1.Confidence Level and Knowledge of Pre-hospital Thrombolysis Therapy of Paramedic in Pre-hospital Care: A Survey
Medicine and Health 2019;14(1):34-43
Data on knowledge, attitude and ST Elevation Myocardial Infarction (STEMI)
electrocardiography (ECG) detection among pre-hospital paramedics in Malaysia
is still scarce. It is imperative to gain this information as a pre-requisite in initiating pre-hospital thrombolysis. This was a descriptive study conducted from May
2016 until November 2017 on paramedics from Universiti Kebangsaan Malaysia
Medical Center (UKMMC) and Kuala Lumpur Hospital (HKL). It was to assess
knowledge on pre-hospital thrombolytic therapy and ECG detection of STEMI.
One hundred and six questionnaires were answered and analyzed. More than
60% of the candidates were unable to detect STEMI ECG changes and lacked of
confidence in handling and administering thrombolytic treatment at the level of
pre-hospital phase. Only 20.8% candidates managed to detect more than 8/10
of the correct ECG pattern in STEMI. Less than 40% of the candidates achieved
more than 80% marks in answering questions regarding STEMI and treatment. It
is concluded that the overall performance and knowledge of paramedic regarding
pre-hospital thrombolytic therapy is generally poor. Further training need to be
done prior to implementing pre-hospital STEMI thrombolytic therapy in Malaysia.
2.Thrombolysis in Acute ST Elevation Myocardial Infarction: Determination of Door to Needle Time in a Tertiary Medical Centre
Medicine and Health 2019;14(1):44-52
Door to needle (DTN) time for thrombolysis in the Emergency Department,
Universiti Kebangsaan Malaysia Medical Centre (ED, UKMMC) is an indicator
that can reduce mortality and morbidity of patients with ST Elevation Myocardial
Infarction (STEMI). This study was conducted to determine factors that influence
DTN time for acute ST Elevation Myocardial Infarction (STEMI) and whether it
has achieved the recommended time of 30 minutes. A cross-sectional study was
conducted among patients diagnosed with acute STEMI and thrombolysed in ED,
UKMMC from June 2016 until March 2017. A data collection sheet was used to
collect patient’s demographic data and clinical data which included time of arrival
to ED, time of initial electrocardiogram (ECG), time of drug preparation and time
of thrombolytic delivery to the patient. A total of 98 patients were included in
this study. Majority of patients (77.6%) were thrombolysed more than 30 minutes
following ED arrival. Mean DTN in ED, UKKMC was 59.28 + 36.01 minutes. The
mean door to ECG time was 7.19 + 8.08 minutes and the mean drug preparation
time was 9.86 + 7.51 minutes. Out of 76 (77.6%) patients that were thrombolysed
after 30 minutes of ED arrival, 59.2% (n=45) were due to multiple disciplinary
referral. Other factors were delay in performing initial ECG 19.8% (n=15), incorrect
initial ECG interpretation 9.2% (n=7) and unavoidable need for prior resuscitation
9.2% (n=7). As a conclusion this study showed that there was an unacceptable
delay in hospital thrombolysis for acute STEMI.
3.Serum Procalcitonin (PCT) - Is there a Role as an Early Biomarker in Infected Diabetic Foot Ulcer (IDFU) Patients?
Omar J ; Ahmad NS ; Che-Soh NAA ; Wan-Azman WN ; Yaacob NM ; Abdul-Ghani NS ; Abdullah MR
Malaysian Orthopaedic Journal 2023;17(No.2):62-69
Introduction: Infected diabetic foot ulcers may lead to
serious complications if not recognised in the early stage.
Diagnosis of infection is particularly challenging at that
stage; thus, a sensitive inflammatory biomarker may be
helpful. We aimed to evaluate the role of procalcitonin (PCT)
as an early biomarker for infected diabetic foot ulcers
(IDFU).
Materials and method: This cross-sectional study was
conducted at Klinik Rawatan Keluarga (KRK), Orthopedic
clinic and wards in Hospital Universiti Sains Malaysia
(USM) from May 2020 to December 2020. A total of 264
participants were recruited and divided into three groups: 50
diabetic patients with no ulcers (control), 107 patients with
non-infected diabetic foot ulcers (NIDFU), and 107 patients
with infected diabetic foot ulcers (IDFU). The level of PCT
was taken for all patients. Total white count (TWC) and Creactive protein (CRP) were taken only for IDFU patients.
Diagnosis of infection was based on the Infectious Disease
Society of America-International Working Group of Diabetic
Foot (IDSA-IMWGDF), and the severity of infection was
graded according to the Wagner Classification.
Results: The level of PCT was higher in IDFU than in
NIDFU and diabetic patient, with a median (IQR) of 0.355
(0.63) ng/mL, 0.077 (0.15) ng/mL and 0.028 (0.02) ng/mL,
respectively. PCT and CRP showed moderate positive
correlations in IDFU patients (p<0.001). The sensitivity and
specificity were 63.6% and 83.2%, respectively, at the best
cut-off at 0.25 ng/mL.
Conclusion: PCT is a valuable biomarker for the diagnosis
of infection; however, it adds little value in the early
diagnosis of IDFU in view of its low sensitivity.